BRD4 and acute myeloid leukemia: The diazepine-based bromodomain and extra-terminal protein (BET) inhibitor JQ1 suppressed functional MYB-p300 in AML cells by inhibition of the reader protein bromodomain-containing protein 4 (BRD4)[201].